EPISODE · Mar 3, 2026 · 42 MIN
Why the MIND Study Matters: Building Clinical Trial Readiness for MED13L with Abigail Svedeen, MS, CGC
from The Voices of MED13L · host The MED13L Foundation
Why the MIND Study Matters: Building Clinical Trial Readiness for MED13LIn this powerful and informative episode of Voices of MED13L, Vanessa sits down with Abigail Sveden, MS, CGC, a genetic counselor at the Boston Children's Hospital and member of the Rosamund Stone Zander Translational Neuroscience Center (TNC).Together, they unpack the critical importance of the MIND Study — MED13L Syndrome Investigation of Natural History and Development — and what it means for families today and for the future of therapeutics.🧬 What You'll Learn in This Episode:What translational neuroscience really means — and how lab discoveries move toward real-world treatmentsWhy natural history studies are essential for clinical trial readinessHow longitudinal data helps researchers understand development over timeThe role of neurobehavioral assessments (including the Vineland) in FDA-approved outcome measuresWhy standardized data collection is critical for future therapeuticsNew clinical observations emerging from the MED13L cohortHow participation today helps prevent future families from facing a “Google search diagnosis”Abigail shares how the TNC brings together experts in genetics, neurodevelopment, EEG, regulatory science, and basic research — all working toward one goal: improving outcomes for individuals with rare neurodevelopmental disorders like MED13L.Vanessa also speaks candidly about the parent experience — the emotional weight of surveys, the importance of being heard, and why documenting your child’s story is one of the most powerful contributions you can make to the community.📊 MIND Study Snapshot🎯 Goal enrollment: 30 participants✅ 27 fully enrolled📈 24 have completed Year One components🔁 Annual follow-up is critical for longitudinal data📍 In-person visits at Boston Children’s Hospital prioritized (virtual options available)Participation includes:Interview-style visits with the study teamNeurobehavioral assessmentsStandardized questionnaires (including the Vineland)Medical record reviewOptional photo and biospecimen contributionThis data builds the foundation for:Clinical trial readiSupport the showResourcesMED13L Awareness Campaign: https://secure.qgiv.com/event/med13lfoundationp2p/Profile Frame for Socials: https://twb.nz/med13lfoundationBe Counted in the 2025 Census: https://med13l.org/patient-registry-genetic-report-stubmission/Million Dollar Bike Ride: https://charity.pledgeit.org/MillionDollarBikeRide/teams/@med13lCommunity Checklist: Google Drive LinkCRID: thecrid.orgCitizen Health: citizen.health/partners/med13l-foundationSimons Searchlight: https://research.simonssearchlight.org/account/createRare-X: rare-x.org/med13lWebsite: med13l.orgFacebook: facebook.com/med13lfoundationInstagram: instagram.com/med...
What this episode covers
Why the MIND Study Matters: Building Clinical Trial Readiness for MED13L In this powerful and informative episode of Voices of MED13L, Vanessa sits down with Abigail Sveden, MS, CGC, a genetic counselor at the Boston Children's Hospital and member of the Rosamund Stone Zander Translational Neuroscience Center (TNC). Together, they unpack the critical importance of the MIND Study — MED13L Syndrome Investigation of Natural History and Development — and what it means for families today and for t...
NOW PLAYING
Why the MIND Study Matters: Building Clinical Trial Readiness for MED13L with Abigail Svedeen, MS, CGC
No transcript for this episode yet
Similar Episodes
Mar 26, 2026 ·1m
Mar 19, 2026 ·34m
Feb 18, 2026 ·11m
Feb 11, 2026 ·45m